Syndicated from In Sequence RSS Feed
The company, which would not disclose the number of shipped instruments, said that more than 70 percent of them are now installed in labs other than large genome centers. It also stressed that longer reads will soon enable customers to perform de novo sequencing.
More...
The company, which would not disclose the number of shipped instruments, said that more than 70 percent of them are now installed in labs other than large genome centers. It also stressed that longer reads will soon enable customers to perform de novo sequencing.
More...